Billings Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-138,891
Closed -$7.19M 10
2019
Q1
$7.19M Sell
138,891
-21,843
-14% -$1.06M 6.06% 9
2018
Q4
$6.33M Sell
160,734
-7,254
-4% -$337K 6.01% 9
2018
Q3
$8.66M Sell
167,988
-155,243
-48% -$7.6M 6.46% 9
2018
Q2
$15.2M Sell
323,231
-6,007
-2% -$249K 11.91% 4
2018
Q1
$11.7M Buy
+329,238
New +$12.9M 9.1% 6

Other funds holding SYNH

Billings Capital Management's SYNH Position: Q2 2019 in Review

Billings Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2019, closing a stake of 138,891 shares — an estimated $7.19M sold.

Billings Capital Management first reported a position in SYNH in Q1 2018 and held it in 5 quarters. The position peaked at $15.2M in Q2 2018. 246 funds tracked by Wall St. Rank hold SYNH as of Q2 2019.

  • Billings Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2019 after selling out during the quarter.
  • Billings Capital Management sold 138,891 Syneos Health, Inc. Class A Common Stock shares in Q2 2019, an estimated $7.19M.
  • Billings Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and held it in 5 quarters.
  • Billings Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $15.2M in Q2 2018.
  • 246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2019.

Based on Billings Capital Management's 13F filing for Q2 2019, filed 19 Aug 2019.